Amy Schumer reveals her dramatic 50-pound weight loss was due to life-threatening Cushing's syndrome. Here's what to know about the hormonal condition and its symptoms.

A weight loss drug dubbed the "triple G" drug for its effectiveness in mimicking three hunger-regulating hormones showed promising results in new data released Thursday by its maker, Eli Lilly.

Eli Lilly said on Thursday its next-generation obesity drug helped patients lose an average of 28.7% of their weight in a late-stage trial, outperforming its blockbuster drug Zepbound and reinforcing the company's lead in the fast-growing market.

Eli Lilly's next-gen obesity drug delivered major weight loss in a trial, but some patients stopped using it after losing too much weight.

Some people, such as those who have spent years gaining muscle mass, can eat lots of calorie-dense food and not gain weight because muscle burns more calories at rest. However, even if you can eat whatever you want and lose or maintain your weight, that doesn't mean it's healthy for you.

The weight-loss drug market is booming, with biotech firms racing to secure their place in a lucrative sector currently dominated by Novo Nordisk and Eli Lilly. Analysts project the industry could rake in $150 billion in annual sales by the next decade.

Kelly Osbourne has finally spoken out about her weight loss. The singer’s mother, Sharon Osbourne, recently appeared on “Piers Morgan Uncensored.” During the interview, the host played a social media clip of her daughter.

Step aside, semaglutide—retatrutide is showing the most impressive weight loss results of any obesity drug to date.

Use BBC.com or the new BBC App to listen to BBC podcasts, Radio 4 and the World Service outside the UK.

Food-packed tables and endless spirits can present a special challenge for those taking GLP-1 medications like Wegovy, Ozempic and Mounjaro.